Vaccinations for adult solid-organ transplant recipients: Current recommendations and protocols

Clinical Microbiology Reviews

Volumn 16, Issue 3, 2003, Pages 357-364

  Duchini, Andrea ^a   Goss, John A ^a   Karpen, Saul ^a   Pockros, Paul J ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; LIVE VACCINE; PNEUMOCOCCUS VACCINE; RUBELLA VACCINE; TETANUS TOXOID; VACCINE; VACCINIA VACCINE; YELLOW FEVER VACCINE;

BACTERIAL INFECTION; CLINICAL PROTOCOL; DIPHTHERIA; DRUG INDICATION; DRUG SAFETY; GRAFT REJECTION; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; REVIEW; RUBELLA; STREPTOCOCCUS INFECTION; TETANUS; VACCINATION; VIRUS INFECTION;

DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; GRAFT REJECTION; HEPATITIS A VACCINES; HEPATITIS B VACCINES; HUMANS; INFLUENZA VACCINES; ORGAN TRANSPLANTATION; PNEUMOCOCCAL VACCINES; VACCINATION;

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE; MYCOBACTERIUM BOVIS BCG; PNEUMOCOCCUS; STREPTOCOCCUS; VACCINIA;

EID: 0038447242     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.16.3.357-364.2003     Document Type: Review

References (104)

1. Acott, P. D., S. H. Lee, H. Bitter-Suermann, J. G. Lawen, and J. F. Crocker. 1996. Infection concomitant with pediatric renal allograft rejection. Transplantation 62:689-691.
2. Admon, D., D. Engelhard, N. Strauss, N. Goldman, and Z. Rones. 1997. Antibody response to influenza immunization in patients after heart transplantation. Vaccine 15:1518-1522.
3. Albat, B., P. Chanez, P. Wintrebert, F. B. Michel, P. Godard, and A. Thevenet. 1993. Influenza following heart transplantation in a patient, an unusual cause of viral pneumonia. Presse Med. 22:174.
4. Amber, I. J., E. M. Gilbert, G. Schiffman, and J. A. Jacobson. 1990. Increased risk of pneumococcal infections in cardiac transplant recipients. Transplantation 49:122-125.
5. Ambrosino, D. M., and D. C. Molrine. 1993. Critical appraisal of immunization strategies for prevention of infection in the compromised host. Hematol. Oncol. Clin. North Am. 7:1027-1050.
6. Anandh, U., B. Bastani, and S. Ballal. 2000. Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients. Am. J. Nephrol. 20:53-56.
7. Arslan, M., R. H. Wiesner, J. J. Poterucha, Jr., and Z. Gross. 2000. Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity post-transplantation. Liver Transpl. 6:191-195.
8. Arslan, M., R. H. Wiesner, C. Sievers, K. Egan, and N. N. Zein. 2001. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transplantation 7:314-320.
9. Aschan, J., O. Ringden, P. Ljungman, J. Andersson, I. Fuchs, and M. Forsgren. 1989. Influenza B in transplant patients. Scand J. Infect. Dis. 21:349-350.
10. Austrian, R. 1981. Pneumococcus: the first one hundred years. Rev. Infect. Dis. 3:183-189.
11. Avery, R. K. 2001. Immunizations in adult immunocompromised patients: which to use and which to avoid. Cleveland Clin. J. Med. 68:337-348.
12. Balloni, A., B. M. Assael, L. Ghio, H. G. Pedrazzi, et al. 1999. Immunity to poliomyelitis, diphteria and tetanus in pediatric patients before and after renal and liver transplantation. Vaccine 17:2507-2511.
13. Blumberg, E. A., C. Albano, T. Pruett, R. Isaacs, J. Fitzpatrick, J. Bergin, C. Crump, and F. G. Hayden. 1996. The immunogenicity of Influenza virus vaccine in solid-organ transplant recipients. Clin. Infect. Dis. 22:295-302.
14. Blumberg, E. A., S. C. Brozena, P. Stutman, D. Wood, H. M. Phan, and D. M. Musher. 2001. Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin. Infect. Dis. 32:307-310.
15. Blumberg, E. A., J. Fitzpatrick, P. C. Stutman, F. G. Hayden, and S. C. Brozena. 1998. Safety of influenza vaccine in heart transplant recipients. J. Heart Lung Transplant. 17:1075-1080.
16. Briggs, W. A., R. J. Rozek, S. D. Migdal, J. L. Shillis, R. G. Brackett, F. B. Brandon, S. K. Mahajan, and F. D. McDonald. 1980. Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. Ann. Intern. Med. 92:471-477.
17. Broyer, M., M. J. Tete, G. Guest, M. F. Gagnadoux, and C. Rouzioux. 1997. Varicella and zoster in Children after Kidney transplantation: Long-term results of vaccination. Pediatrics 99:35-39.
18. Brunell, P. A., J. Wiedeman, C. F. Geiser, L. Frierson, and E. Lydick. 1986. Risk of Herpes zoster in children with leukemia: Varicella vaccine compared with history of chickenpox. Pediatrics 77:53-56.
19. Burbach, G., U. Bienzle, K. Stark, N. Rayes, R. Neuhaus, S. Serke, H. Engelmann, W. Kunzel, G. Turk, and P. Neuhaus. 1999. Influenza vaccination in liver transplant recipients. Transplantation 67:753-755.
20. Burroughs, M., and A. Moscona. 2000. Immunization of pediatric solid-organ transplant candidates and recipients. Clin. Infect. Dis. 30:857-869.
21. Center for Disease Control and Prevention. 2000. Guidelines for preventing opportunistic infections among hemopoietic stem cell transplant recipients. Morb. Mortal. Wkly. Rep. 1-125.
22. Chalasani, N., G. Smallwood, J. Halcomb, M. W. Fried, and T. D. Boyer. 1998. Is vaccination against hepatitis B infection indicated in patients waiting for and after orthotopic liver transplantation. Liver Transplant Surg. 4:128-132.
23. Charest, A. F., J. McDougall, and M. B. Goldstein. 2000. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am. J. Kidney Dis. 36:976-982.
24. Christenson, B., U. Hellstrom, S. P. Sylvan, L. Henriksson, and M. Granstrom. 2000. Impact of a vaccination campaign on adult immunity to diphtheria. Vaccine 19:1133-1140.
25. Cooksley, W. G. E. 2000. What did we learn from the Shanghai hepatitis A epidemic? J. Viral Hep. 7:1-3.
26. Daum, R. S., S. K. Sood, M. T. Osterholm, J. C. Pramberg, P. D. Granoff, K. E. White, and D. M. Granoff. 1989. Decline in serum antibody to the capsule of haemophilus influenzae type b in the immediate post immunization period. J. Pediatr. 114:742-747.
27. Dengler, T. J., N. Strnad, I. Buhring, R. Zimmermann, O. Girgsdies, W. E. Kubler, and S. Zielen. 1998. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 66:1340-1347.
28. Dengler, T. J., N. Strnad, R. Zimmermann, C. Allers, B. H. Markus, S. Nesse, W. Kubler, and S. Zielen. 1996. Pneumococcal vaccination after heart and liver transplantation. Immune response in immunosuppressed patients and in healthy controls. Dtsch. Med. Wochenschr. 121:1519-1525. (In German.)
29. Dengler, T. J., R. Zimmermann, J. Meyer, F. U. Sack, O. Girgsdies, and W. E. Kubler. 1999. Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients. Vaccine 17:867-874.
30. Dominguez, M., R. Barcena, M. Garcia, A. Sanroman, and J. Nuno. 2000. Vaccination against hepatitis B virus in cirrhotics patients on liver transplant waiting list. Liver Transpl. 6:440-442.
31. Duchini, A., R. M. Hendry, L. M. Nyberg, M. E. Viernes, and P. J. Pockros. 2001. Immune response to influenza vaccine in adult liver transplant recipients. Liver Transpl. 7:311-313.
32. Duchini, A., R. M. Hendry, D. C. Redfield, and P. J. Pockros. 2000. Influenza infection in patients before and after liver transplantation. Liver Transpl. 6:531-542.
33. Dumot, J. A., D. S. Barnes, Z. Younussi, S. M. Gordon, R. K. Avery, R. E. Domen, J. M. Henderson, and W. D. Carey. 1999. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am. J. Gastroenterol. 94:1601-1604.
34. Enke, B. U., A. Bokenkamp, G. Offner, P. Bartmann, and J. Brodehl. 1997. Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients. Transplantation 64:237-241.
35. Fabia, R., M. F. Levy, J. Crippin, et al. 1998. De novo hepatitis B infection after liver transplantation: source of disease, incidence and impact. Liver Transpl. Surg. 4:182-184.
36. Flynn, J. T., K. Frisch, D. B. Kershaw, A. B. Sedman, and T. E. Bunchman. 1999. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and-and receiving peritoneal dialysis. Adv. Perit. Dial. 15:269-272.
37. Fraund, S., D. Wagner, K. Pethig, J. Drescher, O. E. Girgsdies, and A. Haverich. 1999. Influenza vaccination in heart transplant recipients. J. Heart Lung Transplant. 18:220-225.
38. Frenkel, L., L. M. Neilsen, A. Garakian, and J. D. Cherry. 1994. A search for persistent measles, mumps and rubella vaccine virus in children with human immunodeficiency virus infection. Arch. Pediatr. Adol. Med. 148:57-60.
39. Gabriel, R., S. Selwyn, D. Brown, J. M. Crossland, L. W. Loughridge, M. N. Morgan, D. I. Prosser, and M. Snow. 1976. Virus infection and acute renal transplant rejection. Nephron 16:282-286.
40. Gershon, A. A. 1993. Immunizations for pediatric transplant patients. Kidney Int. 44:S87-90.
41. Ghio, I., C. Pedrazzi, B. M. Assael, A. Panuccio, M. Foti, and A. Edefonti. 1997. Immunity to diphtheria and tetanus in a young population on a dialysis regimen and with a renal transplant. J. Pediatr. 130:987-989.
42. Goldfarb, N. S., R. Avery, K. Goormastic, et al. 2001. Hypogammaglobulinemia in lung transplant recipients. Transplantation 71:242-246.
43. Grabenstein, J. D. 2001. Immunization and organ transplant donors and recipients. Pharm. Pract. Manage. Q. 20:11-22.
44. Grob, P. J., H. I. Jemelka, U. Binswanger, K. Zaruba, C. Descoeudres, M. Fernex. 1984. Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations. Eur. J. Clin. Microbial. 3:195-198.
45. Gunther, M., K. Stark, R. Neuhaus, P. Reinke, K. Schroder, and U. Biemzle. 2001. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 71:477-479.
46. Hardy, I. R. B., and A. A. Gershon. 1990. Prospects for use of a varicella vaccine in adults. Infect. Dis. Clin. North Am. 4:159-173.
47. Hasan, M. S., J. M. Agosti, K. K. Reynolds, E. Tanzman, J. J. Treanor, T. G. Evans. 1999. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults. J. Infect. Dis. 180:2023-2026.
48. Heineman, T. C., M. L. Clemens-Mann, G. A. Poland, R. M. Jacobson, A. E. Izu, D. Sakamoto, J. Eiden, G. A. Van Nest, and H. H. Hsu. 1999. A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant. Vaccine 17:2769-2778.
49. Henning, K. J., M. H. White, K. A. Sepkowitz, and D. Armstrong. 1997. A national survey of immunization practices following allogenic bone marrow transplantation. JAMA 277:1148-1151.
50. Herzog, K. D., S. P. Dunn, M. R. Langham, and L. M. Marmon. 1989. Association of parainfluenza virus type 3 infection with allograft rejection in a liver transplant recipient. Pediatr. Infect. Dis. J. 8:534-536.
51. Hibberd, P. L., and R. H. Rubin. 1989. Immunization strategies for the Immunocompromised host: the need for immunoadjuvants. Ann. Intern. Med. 110:955-956.
52. Hibberd, P. L., and R. H. Rubin. 1990. Approach to immunization in the immunosuppressed host. Infect. Dis. Clin. North Am. 4:123-142.
53. Hogan, R. N., and H. D. Cavanagh. 1995. Transplantation of comeal tissue from donors with diseases of the central nervous system. Cornea 14:547-553.
54. Horlander, J. C., N. Boyle, R. Manam, M. Schenk, S. Herring, P. Y. Kwo, L. Lumeng, and N. Chalasani. 1999. Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation. Am. J. Med. Sci. 318:304-307.
55. Huzly, D., S. Neife, P. Reinke, K. Schroder, C. Schonfeld, T. Hofmann, and U. Bienzle. 1997. Routine immunizations in adult renal transplant recipients. Transplantation 63:839-845.
56. Jackson, A. C., M. J. Warrell, C. E. Rupprecht, et al. 2003. Management of rabies in humans. Clin. Infect. Dis. 36:60-63.
57. Jacobson, R. M., and G. A. Poland. 2002. The pneumococcal conjugate vaccine. Minerva Pediatr. 54:295-303.
58. Kallinowski, B., C. Benz, L. Buchholz, and W. Stremmel. 1998. Accelerated schedule of hepatitis B vaccination in liver transplant candidates. Transplant Proc. 30:797-799.
59. Kapoor, D., S. R. Aggarwal, N. P. Singh, V. Thakur, and S. K. Sarin. 1999. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients. J. Viral Hepatol. 6:405-409.
60. Kazancioglu, R., M. S. Sever, Yuksel-D. Onel, H. Eraksoy, A. Yildiz, A. V. Celik, S. M. Kayacan, and S. Badur. 2000. Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine. Clin. Transpl. 14:61-65.
61. Keane, W. R., J. H. Helderman, J. Luby, P. Gailiunas, A. R. Hull, and J. P. Kokko. 1978. Epidemic renal transplant rejection associated with influenza A Victoria. Proc. Clin. Dial. Transpl. Forum 8:232-236.
62. Keeffe, E. B. 2000. Hepatitis A in patients with chronic liver disease-severity of illness and prevention with vaccination. J. Viral Hepatitis 7:15-17.
63. Keeffe, E. B., S. Iwarson, B. J. McMahon, et al. 1998. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 27:881-886.
64. Kimball, P., S. Verbeke, M. Flattery, C. Rhodes, and D. Tolman. 2000. Influenza vaccination does not promote cellular and humoral activation among transplant recipients. Transplantation 69:2449-2451.
65. Kitai, I. C., S. King, and A. Gafni. 1993. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients. Clin. Infect. Dis. 17:441-447.
66. Kobashigawa, J. A., Warner-L. Stevenson, B. L. Johnson, J. D. Moriguchi, N. Kawata, D. C. Drinkwater, and H. Laks. 1993. Influenza vaccine does not cause rejection after cardiac transplantation. Transplant. Proc. 25:2738-2739.
67. Krause, P., and D. M. Klinman. 1995. Efficacy, immunogenicity, safety and use of live attenuated chickenpox vaccine. J. Pediatr. 127:518-525.
68. Lahood, N., S. S. Emerson, P. Kumar, and R. U. Sorensen. 1993. Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma. Ann. Allergy 70:289-294.
69. Lee, S. D., C. Y. Chan, M. I. Yu, Y. J. Wang, F. Y. Chang, K. J. Lo, and A. Safary. 1997. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with liver disease. J. Med. Virol. 52:215-218.
70. Lefilliatre, P., and J. P. Villeneuve. 2000. Fulminant hepatitis A in patients with chronic liver disease. Can. J. Public Health 91:168-170.
71. Linnemann, C. C., Jr., M. R. First, and G. Schiffman. 1981. Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch. Intern. Med. 141:1637-1640.
72. Linnemann, C. C., Jr., M. R. First, and G. Schiffman. 1986. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch. Intern. Med. 146:1554-1556.
73. Ljungman, P., E. Fridell, B. Lonnqvist, P. Bolme, M. Bottiger, G. Gahrton, A. Linde, O. Ringden, and B. Wahren. 1989. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps and rubella vaccine. J. Infect. Dis. 159:610-615.
74. Loinaz, C., J. R. deJuannes, E. M. Gonzalez, A. Lopez, C. Lumbreras, R. Gomez, I. Pinto, C. Jimenez, I. Garcia, and A. Fuertes. 1997. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 44:235-238.
75. Mack, D. R., S. A. Chartrand, E. I. Ruby, D. L. Antonson, B. W. Shaw, Jr., and T. G. Heffron. 1996. Influenza vaccination following liver transplantation in children. Liver Transpl. Surg. 2:431-437.
76. Mauch, T. J., N. A. Coruch, D. K. Freese, E. A. Braunlin, D. L. Dunn, and C. E. Kashtan. 1995. Antibody response of pediatric solid-organ transplant recipients to immunization against influenza virus. J. Pediatr. 127:957-960.
77. McCashland, T. M., L. C. Preheim, and M. J. Nielsen. 2000. Pneumococcal vaccine response in cirrhosis and liver transplantation. J. Infect. Dis. 181:757-760.
78. Meuer, S. C., H. Dumann, K. H. Meyer zum Buschenfelde, and T. Kohler. 1989. Low dose interleokin-2 induces systemic immune response against hepatitis B virus surface antigen in immunodeficient non-responders to hepatitis B vaccination. Lancet 1:15-17.
79. Myers, R. P., J. C. Gregor, and P. J. Marotta. 2000. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C. Hepatology 31:834-839.
80. O'Sullivan, J., J. Dark, and K. Gould. 1993. Heamophilus influenzae immunization and timing of cardiac transplantation. Lancet 342:859.
81. Pedrazzi, C., L. Ghio, A. Balloni, A. Panuccio, M. Foti, A. Edefonti, and B. Assael. 1999. Duration of immunity to diphteria and tetanus in young kidney transplant patients. Pediatr Transplant. 3:109-114.
82. Pirofski, L. A., and A. Casadevall. 1998. Use of licensed vaccines for active immunization of the Immunocompromised host. Clin. Microbiol. Rev. 11:1-26.
83. Pirovino, M., E. Lydick, P. J. Grob, S. Arrenbrecht, J. Altofer, and M. Schmid. 1984. Pneumococcal vaccination: the response of patients with alcoholic liver cirrhosis. Hepatology 4:946-949.
84. Pollock, C. A., J. F. Mahony, L. S. Ibels, R. J. Caterson, D. A. Waugh, J. V. Wells, and A. G. Sheil. 1989. Immunoglobulin abnormalities in renal transplant recipients. Transplantation 47:952-956.
85. Rand, E. B., C. A. McCarthy, and P. F. Whitington. 1993. Measles vaccination after orthotopic liver transplantation. J. Pediatr. 123:87-89.
86. Receveur, M. C., R. Thiebaut, S. Vedy, D. Malvy, P. Mercie, and M. L. Bras. 2000. Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases. Clin. Infect. Dis. 31:E7-8.
87. Roggendorf, M. 1996. Epidemiology of tick-borne encephalitis virus in Germany. Infection 24:465-466.
88. Rosman, A. S., P. Basu, K. Galvin, and C. S. Lieber. 1997. Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial. Am. J. Med. 103:217-222.
89. Rytel, M. W., M. P. Dailey, G. Schiffman, R. G. Hoffmann, and W. F. Piering. 1986. Pneumococcal vaccine immunization of patients with renal impairment. Proc. Soc. Exp. Biol. Med. 182:468-473.
90. Sepkowitz, K. A. 2003. How contagious is vaccinia. N. Engl. J. Med. 348:439-446.
91. Sever, M. S., A. Yildiz, H. Eraksoy, S. Badur, D. Yuksel-Onel, B. Gorcin, S. Turk, and R. Erkoc. 1999. Immune response to Haemophilus influenzae type b vaccination in renal transplant recipients with well-functioning allografts. Nephron 81:55-59.
92. Simberkoff, M. S., G. S. Schiffman, J. R. Spicehandler, N. H. Moldover, and J. J. Rahal, Jr. 1983. Radioimmunoassay and opsonic antibody responses to pneumococcal capsular polysaccharide vaccine in serum and ascitic fluid of cirrhotic patients. J. Clin. Microbiol. 18:154-159.
93. Soesman, N. M., G. F. Rimmelzwaan, N. J. Nieuwkoop, W. E. Beyer, H. W. Tilanus, M. H. Kemmeren, H. J. Metselaar, R. A. de Man, A. D. Osterhaus. 2000. Efficacy of influenza vaccination in adult liver transplant recipients. J. Med. Virol. 61:85-93.
94. Stark, K., M. Gunther, R. Neuhaus, P. Reinke, K. Schroder, S. Linnig, and U. Bienzle. 1999. Immunogenecity and safety of hepatitis A vaccine in liver and renal transplant recipients. J. Infect. Dis. 180:2014-2017.
95. Stark, K., M. Gunther, C. Schonfeld, S. G. Tullius, and U. Bienzle. 2002. Immunisations in solid-organ transplant recipients. Lancet 359:957-965.
96. Stiver, H. G., P. Graves, G. Meiklejohn, G. Schroter, and T. C. Eickhoff. 1977. Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients. Infect. Immun. 16:738-741.
97. Versluis, D. J., W. E. Beyer, N. Masurel, G. J. Wenting, and W. Weimar. 1986. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 42:376-379.
98. Vilchez, R. A., J. J. Fung, and S. Kusne. 2000. Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. Transplantation 70:543-545.
99. Villeneuve, E., J. Vincelette, and J. P. Villeneuve. 2000. Ineffectiveness of hepatitis B vaccination in cirrhotic patients waiting for liver transplantation. Can. J. Gastroenterol. 14:59B-62B.
100. Wagner, C. R., and J. D. Hosenpud. 1993. Enhanced lymphocyte proliferative responses to donor-specific aortic endothelial cells following influenza vaccination. Transpl. Immunol. 1:83-85.
101. Wiedmann, M., U. G. Liebert, U. Oesen, H. Porst, M. Wiese, S. Schroeder, U. Halm, J. Mossner, and F. Berr. 2000. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology 32:444-445.
102. Yamani, M. H., R. K. Avery, S. D. Mawhorter, J. B. Young, N. B. Ratliff, R. E. Hobbs, P. M. McCarthy, N. G. Smedira, M. Goormastic, D. Pelegrin, and R. C. Starling. 2001. Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection. J. Heart Lung Transplant. 20:425-430.
103. Zamora, I., J. Simon, M. DaSilva, and I. Piqueras. 1994. Attenuated varicella virus vaccine in children with renal transplants. Pediatr. Nephrol. 8:190-192.
104. Zeldin, G. A., J. Maygers, A. Klein, and P. J. Thuluvath. 2001. Vaccination, screening for malignancy and health maintenance of the liver transplant recipient. J. Clin. Gastroenterol. 32:148-150.